We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Plastic Antibodies Prevent Poisoning in Mouse Model

By LabMedica International staff writers
Posted on 23 Jun 2010
Synthetic plastic nanoparticles have been shown capable of acting like antibodies to selectively attach and remove a toxic substance from the blood of laboratory mice.

Investigators at the University of California, Irvine (USA) in collaboration with colleagues from the University of Shizuoka (Japan) created plastic analogs of an antibody that recognized the poison melittin. More...
Melittin, a peptide of 26 amino acids, is one of the toxic peptides in bee venom.

The artificial antibodies were produced by incubating melittin together with plastic monomers. A chemical reaction was started that allowed the plastic to polymerize around the molecules of melittin, which were then leached out of the matrix. The result was nanoparticles with cavities that matched the structure of melittin.

The investigators reported in the April 26, 2010, online edition of the Journal of the American Chemical Society (JACS) that treating mice that had been injected with a lethal dose of melittin with the synthetic antibodies significantly diminished the mortality and peripheral toxic symptoms of the melittin. In vivo imaging confirmed that the polymer plastic antibodies accelerated clearance of the peptide from the blood and accumulated in the liver.

Commenting on the significance of the results, senior author Dr. Kenneth Shea, professor of medical biochemistry at the University of California, Irvine, said, "This opens the door to serious consideration for these nanoparticles in all applications where antibodies are used.”

Related Links:
University of California, Irvine
University of Shizuoka



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.